EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

The use of remimazolam versus propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis

Ching-Chung Ko, Kuo-Chuan Hung, Amina M Illias, Chong-Chi Chiu, Chia-Hung Yu, Chien-Ming Lin, I-Wen Chen, Cheuk-Kwan Sun

Frontiers in Pharmacology · 06.02.2023 · 14

DOI: 10.3389/fphar.2023.1101728 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 06.02.2023. Verfasst von Ching-Chung Ko und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Chi Mei Medical Center, Tainan city, Taiwan. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The primary objective of this study was to compare the risk of hypotension, as well as the induction and recovery characteristics between remimazolam and propofol in patients receiving surgery under general anesthesia.

Methods

The Embase, Medline, Google scholar, and the Cochrane Library databases were searched from inception to March 2022 for randomized controlled trials The primary outcome was the risk of post-induction hypotension between the two agents, while the secondary outcomes included anesthetic depth, induction efficacy, time to loss of consciousness (LOC), hemodynamic profiles, time to eye opening, extubation time as well as the incidence of injection pain and postoperative nausea/vomiting (PONV).

Results

Meta-analysis of eight studies published from 2020 to 2022 involving 738 patients revealed a significantly lower risk of post-induction hypotension with the use of remimazolam compared to that with propofol [risk ratio (RR) = 0.57, 95% confidence interval (CI): 0.43 to 0.75, p < 0.0001, I 2 = 12%, five studies, 564 patients]. After anesthetic induction, the anesthetic depth measured by bispectral index (BIS) was lighter in the remimazolam group than that in the propofol group (MD = 9.26, 95% confidence interval: 3.06 to 15.47, p = 0.003, I 2 = 94%, five studies, 490 patients). The time to loss of consciousness was also longer in the former compared to the latter (MD = 15.49 s, 95%CI: 6.53 to 24.46, p = 0.0007, I 2 = 61%, three studies, 331 patients). However, the use of remimazolam correlated with a lower risk of injection pain (RR = 0.03, 95%CI: 0.01 to 0.16, p < 0.0001, I 2 = 0%, three studies, 407 patients) despite comparable efficacy of anesthetic induction (RR = 0.98, 95%CI: 0.9 to 1.06, p = 0.57, I 2 = 76%, two studies, 319 patients). Our results demonstrated no difference in time to eye opening, extubation time, and risk of PONV between the two groups.

Conclusion

Remimazolam was associated with a lower risk of post-induction hypotension after anesthetic induction compared with propofol with similar recovery characteristics. Further studies are required to support our findings. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/ ; Identifier: CRD42022320658.

Schlagwörter

Stichwörter der Autor:innen

anesthesiageneral anesthesia (GA)hypotensionpropofolremimazolam

Autor:innen und Institutionen

  • Department of Medical Imaging, Chi Mei Medical Center, Tainan city, Taiwan.
  • Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan city, Taiwan.
  • Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan.
  • Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Department of General Surgery, E-Da Cancer Hospital, I-Shou University Kaohsiung city, Kaohsiung City, Taiwan.

Zitieren

APA

Ko, C. C., Hung, K. C., Illias, A. M., Chiu, C. C., Yu, C. H., Lin, C. M., Chen, I. W., & Sun, C. K. (2023). The use of remimazolam versus propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1101728

Vancouver

Ko CC, Hung KC, Illias AM, Chiu CC, Yu CH, Lin CM, et al. The use of remimazolam versus propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1101728

BibTeX
@article{Ko2023,
  author = {Ko, Ching-Chung and Hung, Kuo-Chuan and Illias, Amina M and Chiu, Chong-Chi and Yu, Chia-Hung and Lin, Chien-Ming and Chen, I-Wen and Sun, Cheuk-Kwan},
  title = {The use of remimazolam versus propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1101728}
}
Kostenlos starten →